Company intelligence / Profile preview

Protealis

Ghent, Belgium

Ownership: Private
Development stage: Other

Overview

Protealis is a commercial-stage company with nine early-maturity soybean varieties currently on the market and registered in Belgium, France, Germany, and Ukraine[3]. The company has successfully completed R&D and demonstrated proof of concept for its microbial inoculants[2]. Positive yield trial results with yellow peas have been achieved[4].

Modalities: Plant breedingSeed technology
Industry: Agriculture & AgTech

Partnerships

VIB (Flanders Institute for Biotechnology)ILVO (Flanders Research Institute for Agriculture, Fisheries and Food)EIC Scaling Club

Beyond the preview

Go deeper on Protealis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protealis.

Explore the full profile